Close
Nordic 9Nordic 9

Seroba Life Sciences (investor - Venture Capital)

Ireland seroba-lifesciences.com
See something wrong or missing? Let us know
Offices:Dublin

Seroba is a leading European life sciences venture capital firm operated out of Ireland.

  • in 2024, Seroba announced the final closing of a fourth fund at €123 million targeting European and American startups developing novel treatments addressing major unmet medical needs.
Average round investment:32.92M USD
Average number per year:2.6
Distribution: 2025 (2)2024 (4)2023 (4)2022 (3)2021 (3) See the entire list
Portfolio companies: Netherlands AzafarosIreland PerfuzeFrance Coave Therapeutics See the entire list
Mostly invests in: Ireland Ireland (10) Health services (18)
See the entire list

Showing 3 of 18 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Seroba Life Sciences mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Seroba Life Sciences

Name Criteria
United Kingdom Aviva Ventures
100%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, Ecommerce, Hardware
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Ireland, France, United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
France AXA IM
100%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Software Services, Ecommerce, Hardware
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: France, Germany, United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Sweden Flat Capital
100%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, Ecommerce, Hardware
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Germany Porsche Ventures
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, Hardware
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
Spain Asabys Partners
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma, Software Services, Hardware
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: France, Germany
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
Germany Boehringer Ingelheim Venture Fund
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma, Software Services, Ecommerce
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: France, Germany, United Kingdom
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
France Eiffel Investment Group
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Software Services, Ecommerce, Hardware
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: France, Germany, Italy
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
Spain Kibo Ventures
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Software Services, Ecommerce
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Germany, United Kingdom
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
Switzerland ABB Technology Ventures (ATV)
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Ecommerce, Hardware
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Ireland, Netherlands, United Kingdom
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Luxembourg Vesalius Biocapital Partners
99%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech, Pharma, Software Services
  • Similar business models: B2B, SAAS, B2C (Retail)
  • Common investees countries: Netherlands, France, Germany
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top